BioHealth News Archive
Sisu’s Life Saving Hemafuse Device Introduced in Five Frontier Hospitals of Kenya – APO Group – Africa Newsroom / Press release
BALTIMORE, United States of America, October 29, 2020/APO Group/ -- Sisu Global’s (SisuGlobal.health) flagship medical device is Hemafuse, a surgical autotransfusion device that is…
Read MoreDr. Carol Nacy, CEO of Sequella Incorporated, joins BioTalk to discuss her career, the evolution of their science, and vision for the future.
Listen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of…
Read MoreDr. Carol Nacy, CEO of Sequella Incorporated, joins BioTalk to discuss her career, the evolution of their science, and vision for the future.
Listen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of…
Read MoreThe risks and rewards of Operation Warp Speed’s approach to vaccines | PBS NewsHour
The race to develop vaccine candidates to prevent COVID-19 represents an unprecedented national and global effort. President Trump and some public health experts say…
Read MoreArmy teams with Johns Hopkins to advance materials research | Article | The United States Army
ABERDEEN PROVING GROUND, Md. -- The U.S. Army signed a new cooperative agreement with Johns Hopkins University Sept. 30, 2020, to advance materials research using artificial intelligence…
Read MoreAlexandria Real Estate Equities, Inc. Achieves the World’s First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City
PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering…
Read MoreFunding Opportunities | MSCRF
We offer six programs to accelerate discovery and commercialization of human stem cell-based technologies. Please verify eligibility, read the appropriate RFA below and apply…
Read MoreUK Biotech Companies Thriving in Maryland and Philadelphia Hubs · BioBuzz
For decades, the United States and the United Kingdom have enjoyed a special relationship that crosses political, economic, and military lines. But, the two…
Read MoreAnnouncing the Maryland Future 20 | Maryland Business News
Following a statewide search to identify Maryland’s most innovative start-up companies with the potential to be the state’s next major business success story, Governor…
Read MoreOS Therapies Acquires All Indications for OST-HER2 (Listeria monocytogenes) in Solid Tumors, Including Canines
CAMBRIDGE, Md., Nov. 17, 2020 /PRNewswire/ -- OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS)…
Read MoreWhat monoclonal antibodies are – and why we need them as well as a vaccine
When President Trump was diagnosed with COVID-19, one of the cutting-edge experimental therapies he received was a mixture of monoclonal antibodies. But now a…
Read MoreMaryland Today | UMD Ranked in Top 10 for Innovation and Entrepreneurship Education for Sixth Straight Year
For the sixth consecutive year, the University of Maryland (UMD) earned a top 10 ranking in The Princeton Review’s annual survey of top schools…
Read MoreSR One Completes Spin-out from GSK and Closes First Fund at $500 Million | Business | thedailytimes.com
SR One, a trans-Atlantic biotech venture capital firm, announced today the close of its first independent fund, having recently completed its spinout from GlaxoSmithKline…
Read MoreThe state of AI in 2020 | McKinsey
The results of this year’s McKinsey Global Survey on artificial intelligence (AI) suggest that organizations are using AI as a tool for generating value.…
Read More